Ridgetech, Inc. (NASDAQ:RDGT) — Market Cap & Net Worth
Market Cap & Net Worth: Ridgetech, Inc. (RDGT)
Ridgetech, Inc. (NASDAQ:RDGT) has a market capitalization of $678.94K ($678.94K) as of August 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30773 globally and #6156 in its home market, demonstrating a -45.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ridgetech, Inc.'s stock price $0.76 by its total outstanding shares 898906 (898.91K). See how much does Ridgetech, Inc. reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
Ridgetech, Inc. Market Cap History: 2025 to 2026
Ridgetech, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $2.56 Million to $678.94K (0.00% CAGR).
Ridgetech, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ridgetech, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Ridgetech, Inc.'s market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.25x
Ridgetech, Inc.'s market cap is 0.25 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $2.56 Million | $119.97 Million | $10.19 Million | 0.02x | 0.25x |
Competitor Companies of RDGT by Market Capitalization
Companies near Ridgetech, Inc. in the global market cap rankings as of August 2, 2026.
Key companies related to Ridgetech, Inc. by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1572 globally with a market cap of $15.56 Billion USD ( €13.31 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2161 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2504 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3044 globally with a market cap of $6.34 Billion USD ( R$32.31 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1572 | JD HEALTH INTL LTD | F:8ZN | $15.56 Billion | €4.29 |
| #2161 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2504 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3044 | Raia Drogasil S.A | SA:RADL3 | $6.34 Billion | R$18.48 |
Ridgetech, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Ridgetech, Inc.'s market cap moved from $2.56 Million to $ 678.94K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $678.94K | -73.50% |
| 2025 | $2.56 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 2nd, 2026 the market cap of Ridgetech, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $678.94K USD |
| MoneyControl | $678.94K USD |
| MarketWatch | $678.94K USD |
| marketcap.company | $678.94K USD |
| Reuters | $678.94K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ridgetech, Inc.
Ridgetech, Inc. operates as a wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. It operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. The company engages in offline and online wholesale distribution of pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, tra… Read more